Development of a Premature Stop Codon-detection method based on a bacterial two-hybrid system

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Premature Stop Codons (PSCs) are vital genetic markers for hereditary cancers like breast and colorectal cancer.
• Current in vivo detection methods using yeast or bacteria have limitations, including specificity issues and false positives from translation re-initiation.
• There is a need for a robust system to detect PSCs resistant to bacterial translation re-initiation.

Purpose of the Study:

• To design and validate a novel recombinant plasmid for accurate detection of PSCs in human genes.
• To ensure the developed system is resistant to bacterial translation re-initiation, a common source of diagnostic errors.
• To create a cost-effective and straightforward diagnostic tool for genetic analysis.

Main Methods:

• A functional recombinant plasmid, pREAL, was engineered using a bacterial two-hybrid system.
• The system relies on the in vivo translation of fused adenylate cyclase fragments, where PSCs inhibit enzymatic activity.
• Mutated brca1 and msh2 gene fragments were inserted to test PSC detection accuracy and resistance to re-initiation.

Main Results:

• The pREAL system accurately detected PSCs in human brca1 and msh2 gene fragments.
• Western Blot analysis confirmed translation re-initiation events in all tested colonies, highlighting pREAL's resistance to false negatives.
• The system successfully diagnosed wild-type, homozygous, and heterozygous patients in an HNPCC family with an msh2 nonsense mutation.

Conclusions:

• The pREAL plasmid is a validated tool for detecting PSCs in disease-related human genes.
• The system demonstrates resistance to translation re-initiation, improving diagnostic accuracy.
• pREAL offers an easy, low-cost method for detecting pathogenic mutations and analyzing separate alleles.